nivolumab,ipilimumab,sunitinib
bms,pfizer
['gu ', 'hcrn,gu16,260', '/ipi', 'hcrn,gu,16,260', 'rcc,(-irccs),(-srcc),(-urcc)', 'ca,209,214', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'ca209,669', 'cm214', 'nivo', 'bms', 'eqrx']
#gu23
#dr.atkins presents the hcrn gu16-260-cohort a:
-nivo monotherapy with salvage nivo/pi in non-responders is active with tfs and trae-free tfs
- particularly noted in pts with favorable risk disease 
GU Oncologist/Clinical Trials/ Experimental Therapeutics @UCD_Cancer @UCDavisHealth via @uofcincy @GoBEARCATS. Tweets= My opinions #RCC #ASCO #immunotherapy